NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencepha...
Weekly Recap | NMTC.US -12.81%, consensus target well above spot
NeuroOne Medical Technologies shares are trading higher after the company announced it has completed three separate large-animal procedures using its next-generation StereoCED platform.
NeuroOne Advances StereoCED Toward Human Clinical Studies
NeuroOne reports successful large-animal procedures using next-generation StereoCED platform
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript
Analyst Justin Walsh Reiterates Buy on NeuroOne, Maintains $8 Target on Partner-Driven RF Ablation Growth and Pipeline Upside